Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.
The Food and Drug Administration will not approve generic versions of Purdue Pharma's painkiller OxyContin based on earlier versions of the drug that did not include features to thwart abuse, the agency said.
Frito-Lay, a division of PepsiCo, announced this week the company is introducing completely "re-imagined" packaging across its Lay's Wavy brand line of chips and is adding a new garlic-flavored chip to the lineup.
DSN spoke at length with two Catamaran executives — Albert Thigpen, SVP pharmacy operations and industry relations, and Sumit Dutta, SVP and chief medical officer — about the PBM’s new approach to managed pharmacy care and the changes driving that strategy.
This ain’t your mother’s Olay. That’s essentially the message that the long-standing skin care brand is sending to women in their 20s with its new Fresh Effects collection that hit shelves in January with a new, innovative approach to in-store shelving. To learn more about this unprecedented launch for Olay, Drug Store News talked with Janine Miletic, associate marketing director for Olay Global.
No longer will the SymphonyIRI Group crunch data for the betterment of CPG companies everywhere, the company's president and CEO Andrew Appel told a packed conference room at the data aggregator's 2013 Summit. At least not as SymphonyIRI Group.
Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.
Kool-Aid, a Kraft Foods brand, announced the launch of a new multimedia campaign to reintroduce the company's iconic Kool-Aid Man "spokespitcher" that will coincide with the release of a new liquid drink mix available on store shelves now.
Nestlé USA unveiled its new "Balance Your Plate with Nestlé" education campaign to help consumers build nutritious, convenient meals and offer a toolkit to healthcare professionals in guiding their customers to make healthier meals.
The Food and Drug Administration is granting an expedited application process to a company that has developed a treatment for a condition related to Parkinson's disease, meaning that it can cancel a planned late-stage clinical trial, the company said.